Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

3.79GBp
8 Dec 2016
Change (% chg)

-0.13p (-3.32%)
Prev Close
3.92p
Open
3.90p
Day's High
3.90p
Day's Low
3.70p
Volume
21,818,772
Avg. Vol
4,144,532
52-wk High
8.45p
52-wk Low
2.98p

Latest Key Developments (Source: Significant Developments)

Oxford Biomedica says Chief Development Officer Blake to leave in Aug
Thursday, 12 May 2016 02:11am EDT 

Oxford Biomedica Plc : Announces that Dr Paul Blake will leave group when his current contract expires at end of August 2016. .Blake was appointed to Oxford Biomedica's board as a non-executive director in January 2010 and subsequently he became chief development officer in September 2014..  Full Article

Oxford Biomedica PLC secures $50 million loan with oberland capital
Friday, 1 May 2015 02:00am EDT 

Oxford Biomedica PLC:Says that it has secured a $50 million loan facility from a subsidiary of Oberland Capital Healthcare.The funds will be used to invest in the Group's capacity expansion to enable it to deliver on commitments under its manufacturing agreement with Novartis and for pipeline advancements and product acquisitions.  Full Article

BRIEF-Oxford Biomedica inks strategic alliance with Orchard Therapeutics

* Oxford Biomedica announces a strategic alliance with Orchard Therapeutics